Partner Content Partner Content HPAPI 2020 conference to discuss containment solutions and A... HPAPI Conference
Events Partner Content Highly Potent Active Pharmaceutical Ingredients (HPAPI) SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
Partner Content Partner Content The Latest Innovations in HPAPI Manufacturing Technologies HPAPI Technologies
Partner Content Partner Content The need for a blueprint emergency plan to avoid a HPAPI cri... HPAPI Safety Strategies
Partner Content Partner Content Insights into HPAPI Containment and Banding Strategies HPAPI USA Updates
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
